Aristides Garces
Family Medicine · O Fallon, ILNPI 1679672273
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 29.2% of the total. Reporting peaked in 2020 at $644 and has fallen 65.8% since, to $220 in 2023.
Across 145 payments — averaging $14.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$620
- Pfizer$244
- AstraZeneca$179
- GSK$174
- Novo Nordisk$144
- Otsuka America Pharmaceutical, Inc.$124
- plus $643 from 17 others
What the payments were for
- Food & beverage$2,127100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $620 |
| Pfizer | 17 | $244 |
| AstraZeneca | 12 | $179 |
| GSK | 13 | $174 |
| Novo Nordisk | 10 | $144 |
| Otsuka America Pharmaceutical, Inc. | 7 | $124 |
| Novartis | 6 | $94 |
| Lilly USA, LLC | 6 | $87 |
| Sunovion Pharmaceuticals Inc. | 5 | $81 |
| Merck | 3 | $53 |
| Amgen | 3 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $39 |
| Alkermes, Inc. | 2 | $32 |
| Eisai Inc. | 2 | $30 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Redhill Biopharma Inc. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $26 |
| Lundbeck LLC | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Abbott | 1 | $12 |
| Mylan Specialty L.p. | 1 | $12 |
How this compares
$2,127 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $153 |
Paid to pharmacies, not to this prescriber.
Other family medicine in O Fallon
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.